Research is being conducted on the effectiveness of the BNT162b2 vaccine against the omicron variant, with studies taking place in various locations, including south africa and the usa. The vaccine's effectiveness is being evaluated in different populations, including children and adolescents. Multiple studies are also comparing the effectiveness of different vaccines, including BNT162b2 and others, against omicron and delta variants.